Kalehua Capital Management LLC
Holdings as of 2026-06-30, filed 2026-08-19
This is history, not a current position. These holdings describe 2026-06-30, and the report became public 50 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
26
Value reported by manager
$174M
Sum of our stored positions
$174M
should match the line above
Disclosure lag
50 d
quarter end to filing
Top 5 concentration
47.9%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls
Positions
26 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| EA SERIES TRUST | ALPHA ARCH 1-3 | $26.5M | 226,188 | — | 02072L565 |
| Veradermics Inc | COMMON STOCK | $17.9M | 145,695 | — | 922967104 |
| X4 Pharmaceuticals Inc | COM NEW | $17.4M | 3,722,840 | — | 98420X202 |
| Compass Pathways Plc | SPONSORED ADS | $11.6M | 819,692 | — | 20451W101 |
| Surrozen Inc | COM NEW | $10M | 385,178 | — | 86889P208 |
| Aclaris Therapeutics Inc | COM | $9.7M | 1,832,365 | — | 00461U105 |
| Sionna Therapeutics Inc | COM | $8.7M | 197,072 | — | 829401108 |
| Inhibikase Therapeutics Inc | COM NEW | $7.8M | 3,821,890 | — | 45719W205 |
| Pharvaris NV | COM | $6.9M | 198,772 | — | N69605108 |
| Karyopharm Therapeutics Inc | COM NEW | $6.7M | 685,644 | — | 48576U205 |
| Septerna Inc | COM | $6.5M | 194,544 | — | 81734D104 |
| Inflarx Nv | COM | $6.5M | 2,897,769 | — | N44821101 |
| Cyclerion Therapeutics Inc | COM | $5.6M | 1,651,350 | — | 23255M204 |
| Korro Bio Inc | COM | $5.3M | 405,040 | — | 500946108 |
| Uniqure Nv | SHS | $3.7M | 79,407 | — | N90064101 |
| LeonaBio Inc | COM | $3.6M | 393,701 | — | 04746L203 |
| Damora Therapeutics Inc | COM NEW | $3.6M | 139,000 | — | 36322Q206 |
| MoonLake Immunotherapeutics | CLASS A ORD | $3.4M | 175,734 | — | 61559X104 |
| Adlai Nortye | SPONSORED ADS | $2.6M | 226,415 | — | 00704R109 |
| Tyra Biosciences Inc | COM | $2.4M | 74,465 | — | 90240B106 |
| Nuvectis Pharma Inc | COM | $1.8M | 100,000 | — | 67080T108 |
| Gossamer Bio Inc | COM | $1.8M | 11,149,363 | — | 38341P102 |
| Milestone Pharmaceuticals Inc | COM | $1.7M | 1,269,237 | — | 59935V107 |
| Atyr Pharma Inc | COM NEW | $1.1M | 1,788,167 | — | 002120202 |
| Instil Bio Inc | COM NEW | $765.9K | 99,600 | — | 45783C200 |
| Tscan Therapeutics Inc | COM | $445.8K | 454,876 | — | 89854M101 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-19